T helper cell (CD4+ T cell): role, types and clinical importance

Functions and mechanisms

T helper cells recognize peptide fragments presented on MHC class II molecules of antigen-presenting cells. After activation they provide essential help to effector cells: they stimulate antibody production by B cells, and enhance the activity of cytotoxic T cells and phagocytes. Their actions make immune responses more effective against pathogens such as bacteria and viruses. Key features include antigen recognition, co-stimulatory signals, and cytokine secretion to shape the nature of the response.

Subsets and specialized roles

• Th1 — promotes cellular immunity against intracellular microbes.
• Th2 — supports antibody production and responses to parasites.
• Th17 — involved in defence at mucosal surfaces and inflammation.
• Tfh (follicular helper) — helps B cells in germinal centers to produce high-affinity antibodies.
• Treg (regulatory) — limits immune responses and maintains tolerance.

Development, activation and memory

Naive T helper cells are activated when antigen-presenting cells (for example dendritic cells) display antigen on MHC II along with co-stimulatory signals. The local cytokine environment and other signals drive differentiation into one of the functional subsets. Some activated cells become long-lived memory T helper cells that respond more rapidly on re-exposure to the same pathogen, an important principle behind vaccination.

Clinical significance and notable facts

T helper cells are central to effective immunity but also play roles in disease. The human immunodeficiency virus (HIV) selectively infects CD4+ T helper cells, undermining immune coordination and leading to immunodeficiency. Abnormal T helper responses contribute to autoimmune disorders and allergies. Clinically, CD4 counts are used to monitor immune status in HIV infection, and many vaccines aim to elicit durable T helper responses. Important distinctions include the MHC-II restriction of CD4+ cells versus CD8+ cytotoxic cells and the therapeutic targeting of T helper pathways in immunology and oncology.